Artificial Intelligence Discovers Potent Antibiotic
Artificial Intelligence Discovers Potent Antibiotic
Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.
Artificial Intelligence Discovers Potent Antibiotic
Artificial Intelligence Discovers Potent Antibiotic

Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.

Researchers used a machine-learning platform to test more than 100 million molecules for antibacterial activity.

C. difficile
fmt fecal matter transplant microbiome c. difficile
Curious Cure: Human Waste
Kendall Powell | Aug 12, 2019
Studies point to the life-saving record of fecal transplants for patients infected with C. diff, despite a recent death. Doctors are now testing the procedure for other conditions.
Fecal Transplants More Successful from “Super-Donors”
Shawna Williams | Jan 22, 2019
A review finds that for several conditions, poop from certain healthy people is more likely to provide relief for recipients.
Fecal Transplant Pill Fails Trial
Jef Akst | Aug 1, 2016
Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.
Microbiome Teams Up Against C. diff
Jef Akst | Jul 14, 2015
Researchers build a mathematical model that can predict whether a mouse will be infected by Clostridium difficile based on the microbes found in its GI tract.
Fecal Pill Treats Gut Infection
Bob Grant | Oct 11, 2014
In a preliminary study, patients with recurring Clostridium difficile infections found relief from diarrhea by ingesting frozen fecal matter from healthy volunteers.
Fecal Pills
Abby Olena | Oct 7, 2013
A study shows that fecal transplants in an oral capsule form are an effective treatment for Clostridium difficile infection.
Bacterial Cocktail Treats Infection
Edyta Zielinska | Oct 28, 2012
Mice fed a mix of six strains of bacteria were able to fight a C. difficile infection that causes deadly diarrhea and is resistant to most types of treatment.
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011
Clostridium difficile is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.